Trials / Completed
CompletedNCT00051025
Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
A Randomized, Multicenter, Phase II Evaluation of ONTAK (Denileukin Diftitox) in Patients With Previously Treated, Indolent, B-Cell, Non-Hodgkin's Lymphoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to look at the safety and effectiveness of ONTAK in previously treated patients with NHL.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONTAK |
Timeline
- Start date
- 2000-05-01
- Primary completion
- 2001-01-01
- Completion
- 2006-09-01
- First posted
- 2003-01-03
- Last updated
- 2012-07-13
- Results posted
- 2011-08-03
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00051025. Inclusion in this directory is not an endorsement.